HFA Discoveries

Exploring the Frontiers of Heart Failure Science

HFA Discoveries

Get the best available heart failure knowledge and the latest clinical advances, carefully selected, right here, available at no charge.

Watch on-demand webinars on Late-Breaking Trials, and access clinical cases, important HFA position papers, and more.

Open until 20 September to everyone with a My ESC account. HFA Fellows, and HFA Silver and Gold Members enjoy access all year round.

Late-Breaking Science

European Journal of Heart Failure Supplement

Access all the scientific publications in one document

Access and read

Immediate past sessions on demand

Pharmacosmos - IV iron in heart failure – what we know and w[..]

AstraZeneca - SGLT2 inhibition: Making waves in the heart fa[..]

Device therapies in Heart failure continuum of care: time to[..]

Treating hyperkalaemia: A step towards achieving optimal RAA[..]

Late-Breaking Science Session 1 – Clinical Trial Update

Title

Speaker

Slides

Video

Q&A

Title: Late-Breaking Science Session 1 – Clinical Trial Update.

Speaker: P Seferovic (Belgrade,RS), B Pieske (Berlin,DE), R De Boer (Groningen,NL), AM Jackson (Glasgow,GB), W Doehner (Berlin,DE), T Damy (Creteil,FR), L Hill (Co.Antrim,GB)

NA

Video:
Title: Effect of Vericiguat on Left Ventricular Function: The VICTORIA Echocardiographic Sub-Study.

Speaker: B Pieske (Berlin,DE)

NA

Video:
Title: Dapagliflozin and diuretic use in patients with heart failure and reduced ejection fraction in DAPA-HF .

Speaker: AM Jackson (Glasgow,GB)

NA

Video:
Title: The Tafamidis in Transthyretin Cardiomyopathy Clinical Trial.

Speaker: T Damy (Creteil,FR)

NA

Video:

Late-Breaking Science Session 2 – Registries

Title

Speaker

Slides

Video

Q&A

Title: Late-Breaking Science Session 2 – Registries.

Speaker: S Stewart (Blackwood,AU), A Coats (Warwickshire,GB), G Savarese (Stockholm,SE), L Lund (Stockholm,SE), D Playford (Fremantle,AU), EA Jankowska (Wroclaw,PL), M Lainscak (Murska Sobota,SI)

NA

Video:
Title: Ejection fraction and mortality in 499,153 men and women: clarifying sex-based differences in the national echocardiography database of Australia.

Speaker: S Stewart (Blackwood,AU)

NA

Video:
Title: Eligibility for sacubitril/valsartan in heart failure across the ejection fraction spectrum: real world data from the Swedish Heart Failure Registry.

Speaker: G Savarese (Stockholm,SE)

NA

Video:
Title: Preserved ejection fraction and structural heart disease in 446,848 patients: Lessons from the National Echocardiography Database of Australia.

Speaker: D Playford (Fremantle,AU)

NA

Video:

Late-Breaking Science Session 3 – HFpEF

Title

Speaker

Slides

Video

Q&A

Title: Late-Breaking Science Session 3 – HFpEF.

Speaker: JE Udelson (Boston,US), J Bauersachs (Hannover,DE), F Ruschitzka (Zurich,CH), B Moura (Porto,PT), PW Armstrong (Alberta,CA), W Mullens (Genk,BE), M Rienstra (Groningen,NL), G van Woerden (Groningen,NL)

NA

Video:
Title: Multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the sGC stimulator praliciguat over 12 weeks in patients with HFpEF.

Speaker: JE Udelson (Boston,US)

NA

Video:
Title: Ventricular tachyarrhythmia detection by Implantable loop recording in Patients with HFPEF: Results of The VIP-HF study.

Speaker: M Rienstra (Groningen,NL), G van Woerden (Groningen,NL)

NA

Video:
Title: The VITALITY-HFpEF Trial (Evaluate the Efficacy and Safety of the Oral sGC Stimulator Vericiguat to Improve Physical Functioning in Daily Living Activities of Patients With Heart Failure and Preserved.

Speaker: PW Armstrong (Alberta,CA)

NA

Video:

Late-Breaking Science Session 4 – Acute Heart Failure

Title

Speaker

Slides

Video

Q&A

Title: Late-Breaking Science Session 4 – Acute Heart Failure.

Speaker: S Harikrishnan (Trivandrum,IN), G Filippatos (Athens,GR), GM Felker (Durham,US), O Chioncel (Bucuresti,RO), S Senger (Durham,US), D Milicic (Zagreb,HR), T Ben Gal (Ramat Hasharon,IL)

NA

Video:
Title: High in-hospital and 90-day mortality in acute decompensated heart failure patients from 50 centres across India: Findings from the National Heart Failure Registry, India.

Speaker: S Harikrishnan (Trivandrum,IN)

NA

Video:
Title: The STAND-UP AHF (STudy Assessing Nitoxyl Donor Upon Presentation with Acute Heart Failure): A Phase 2, randomized double blind placebo-controlled trial.

Speaker: GM Felker (Durham,US)

NA

Video:
Title: Acute heart failure as a distinctive disorder: an analysis from BIOSTAT-CHF.

Speaker: S Senger (Durham,US)

NA

Video:

Late-Breaking Science Session 5 – Monitoring

Title

Speaker

Slides

Video

Q&A

Title: Late-Breaking Science Session 5 – Monitoring.

Speaker: A Pathak (Monte Carlo,MC), J Backs (Heidelberg,DE), M Lainscak (Murska Sobota,SI), T Jaarsma (Norrkoping,SE), J Lindenfeld (Nashville,US), W Mullens (Genk,BE), T Thum (Hannover,DE)

NA

Video:
Title: Telemonitoring versus standard of care in heart failure: results of the OSICAT morbidity/mortality outcome study conducted in France.

Speaker: A Pathak (Monte Carlo,MC)

NA

Video:
Title: Heart failure management optimisation in nursing homes using point-of-care ultrasonography: the HARMONIOUS study.

Speaker: M Lainscak (Murska Sobota,SI)

NA

Video:
Title: Patient-reported outcomes with empagliflozin in the EMPERIAL trials.

Speaker: J Lindenfeld (Nashville,US)

NA

Video:

Late-Breaking Science Session 6 – Pharmacotherapy

Title

Speaker

Slides

Video

Q&A

Title: Late-Breaking Science Session 6 – Pharmacotherapy.

Speaker: A Voors (Groningen,NL), M Metra (Brescia,IT), J Ezekowitz (Edmonton,CA), K F Docherty (Glasgow,GB), J Celutkiene (Vilnius,LT), Y Lopatin (Volgograd,RU), T Thum (Hannover,DE)

NA

Video:
Title: Phase 2a Study of Danicamtiv (MYK-491) in Patients with Chronic Heart Failure with Reduced Ejection Fraction (HFrEF).

Speaker: A Voors (Groningen,NL)

NA

Video:
Title: The VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) trial.

Speaker: J Ezekowitz (Edmonton,CA)

NA

Video:
Title: Effect of dapagliflozin on outpatient worsening in patients with heart failure and reduced ejection fraction: A prespecified analysis of DAPA-HF.

Speaker: K F Docherty (Glasgow,GB)

NA

Video:

Late-Breaking Science Session 7 – Prevention

Title

Speaker

Slides

Video

Q&A

Title: Late-Breaking Science Session 7 – Prevention.

Speaker: M Lainscak (Murska Sobota,SI), S Heymans (Maastricht,NL), A Lyon (London,GB), P Ponikowski (Wroclaw,PL), EA Jankowska (Wroclaw,PL), W Abraham (Columbus,US), J Lindenfeld (Nashville,US)

NA

Video:
Title: High prevalence of ESC-defined heart failure in an urban community: The SOBOTA-HF study.

Speaker: M Lainscak (Murska Sobota,SI)

NA

Video:
Title: Baroreflex activation therapy in patients with heart failure and reduced ejection fraction: responder rates and quality of life measures analyzed by gender.

Speaker: J Lindenfeld (Nashville,US)

NA

Video:
Title: Favourable effects of empagliflozin on congestion, diuretic use and all-cause healthcare resource utilisation in the EMPERIAL trials.

Speaker: P Ponikowski (Wroclaw,PL), W Abraham (Columbus,US)

NA

Video:

Stay up to date!

Great science, direct to your inboxSign up for free to the heart failure news bulletin

Industry Discoveries

Title	Industry
Device therapies in Heart failure continuum of care: time to treat!	Abbott
Emerging data in Heart Failure: are we doing enough to improve patients' survival and quality of life?	Servier
Experts on the Spot: Cardiac remodelling and outcomes	Novartis
Inotropes and Inodilators in Acute and Advanced Heart Failure	Orion Pharma
IV iron in heart failure - what we know and what we don’t	Pharmacosmos
Latest Device-Based Tools and Techniques for Improving Heart Failure Outcomes	Medtronic
Remote Management of Device Heart Failure Patients: New Paradigms for the Post-COVID-19 Era	Medtronic
Reversing cardiac remodelling and improving outcomes in heart failure: what are our first-choice treatments?	Novartis
SGLT2 inhibition: Making waves in the heart failure landscape	CHANGE IME in partnership with Leicester Diabetes Centre
The Hidden Threat of ATTR-CM: Identification, Diagnosis, and Management	Pfizer
Treating hyperkalaemia: A step towards achieving optimal RAASi therapy?	AstraZeneca
Treating Secondary Mitral Regurgitation: Changing the Course of Heart Failure	Abbott

Publications

Interact and exchange with the authors using the feature "Ask a question" which will direct your question automatically to the author.
Please note the most recent presentations are displayed at the top of the list.